The US and Singapore are both strong tokenization bases with similar securities logic but a big tax difference. In the US, the SEC governs via exemptions like Reg D; in Singapore, MAS treats a security token as a capital markets product under the Securities and Futures Act, with comparable prospectus exemptions for accredited investors. The standout differences: Singapore has no general capital gains tax, and MAS actively runs tokenization pilots through Project Guardian. For many issuers it comes down to investor base and tax.

Similar securities logic

Both apply substance over form and both lean on exemptions for private raises. The US uses Reg D and friends; Singapore's SFA exempts offers to accredited and institutional investors and small personal offers from the prospectus requirement.

So the core mechanics rhyme: classify the token as a security, then raise under an exemption to a qualified base, or do a full public offer with disclosure. An issuer comfortable with US exemptions will find Singapore familiar.

Where they diverge

Two differences stand out. First, tax: Singapore has no general capital gains tax, while the US taxes gains under IRS rules - a meaningful edge for Singapore-based investors and funds. Second, posture: MAS runs Project Guardian, actively piloting tokenization with major institutions.

Singapore also offers a single regulator and jurisdiction, versus the US federal-plus-state (blue sky) layering. For a globally minded issuer, those are real advantages.

Investor reach

The US market is enormous, with a deep pool of accredited investors and institutions - unmatched scale. Singapore is a gateway to Asian capital and a hub for international investors, with clear accredited-investor rules.

So the choice often tracks your target investors: US scale versus Singapore's Asian reach and tax efficiency. Many institutional issuers establish in both over time.

Which to choose

If your investors and assets are US-centric, the US path is natural despite the tax and state-law layers. If you want Asian reach, tax efficiency, and a regulator that actively supports tokenization, Singapore is compelling.

Read the Singapore regulation pillar and the US map together, and decide with counsel in the relevant market.

The numbers that decide it

Put real figures on the contrast. In the US, a Reg D 506(b) or 506(c) raise is open to accredited investors - broadly income over $200,000 (or $300,000 jointly) or net worth over $1 million excluding your home - with no cap on the amount raised. Singapore's accredited threshold is set in local terms: net personal assets over S$2 million, income over S$300,000, or financial assets over S$1 million, and the SFA also allows a small-offer exemption capped at S$5 million in any 12 months and a private placement to no more than 50 persons.

On tax the gap is stark and simple. A US investor pays capital-gains tax - long-term rates up to 20%, plus the 3.8% net investment income tax and any state tax - while a Singapore private investor usually pays nothing on disposal. That single difference can swing a fund's after-tax return by double digits over a holding period.

Two nuances keep it honest. US depth is unmatched - the accredited-investor pool runs to tens of millions of households - and if you trade actively in Singapore, IRAS can recharacterise your gains as taxable trading income. So the headline favours Singapore on tax and the US on scale, which is why large issuers often end up in both.

Where to go next

• Next: EU MiCA vs US SEC.
• Go deeper: the Singapore regulation pillar.
• Glossary: accredited investor.

Sources: U.S. SEC (sec.gov); Monetary Authority of Singapore (mas.gov.sg), as of 2026.